HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Saeger, W. Articles by Petersenn, S. Search for Related Content PubMed PubMed Citation Articles by Saeger, W. Articles by Petersenn, S.

Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry

Institute of Pathology, Marienkrakenhaus, Alfredstraße 9 D-22087 Hamburg, ¹ Department of Neurosurgery, University of Hamburg, Germany, ² Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany, ³ Center of Endocrine Neurosurgery, International Neuroscience Institute, Hannover, Germany, ⁴ Department of Endocrinology, Klinikum Benjamin-Fraenklin, Free University of Berlin, Berlin, Germany and ⁵ Division of Endocrinology, Medical Center, University of Duisburg-Essen, Essen, Germany

(Correspondence should be addressed to W Saeger; Email: WolfgangSaeger.HH{at}t-online.de)

In 1996, the German Registry of Pituitary Tumors was founded by the Pituitary Section of the German Society of Endocrinology as a reference center for collection and consultant pathohistological studies of pituitary tumors. The experiences of the first 10 years of this registry based on 4122 cases will herein be reported. The data supplement former collections of the years 1970–1995 with 3480 surgically removed tumors or lesions of the pituitary region. The cases were studied using histology, immunostainings and in some cases also molecular pathology or electron microscopy. The adenomas were classified according to the current World Health Organization classification in the version of 2004. From 1996 on 3489 adenomas (84.6%), 5 pituitary carcinomas (0.12%), 133 craniophar-yngiomas (3.2%), 39 meningiomas (0.94%), 25 metastases (0.6%), 22 chordomas (0.5%), 115 cystic non-neoplastic lesions (2.8%), and 46 inflammatory lesions (1.1%, 248 other lesions or normal tissue (6.0%)) were collected by us. The adenomas (100%) were classified into densely granulated GH cell adenomas (9.2%), sparsely granulated GH cell adenomas (6.3%), sparsely granulated prolactin (PRL) cell adenomas (8.9%), densely granulated PRL cell adenomas (0.3%), mixed GH/PRL cell adenomas (5.2%), mammosomatotropic adenomas (1.1%), acidophilic stem cell adenomas (0.2%), densely granulated ACTH cell adenomas (7.2%), sparsely granulated ACTH cell adenomas (7.9%), Crooke cell adenomas (0.03%), TSH cell adenomas (1.5%), FSH/LH cell adenomas (24.8%), null cell adenomas (19.3%), null cell adenoma, oncocytic variant (5.8%), and plurihormonal adenomas (1.3%). Following the WHO classification of 2004, the new entity ‘atypical adenoma’ was found in 12 cases in 2005. Various prognostic parameters and clinical implications are discussed.

This article has been cited by other articles:

				M. Joubert, R. Verdon, and Y. Reznik Transient pituitary enlargement with central hypogonadism secondary to bilateral cavernous sinus thrombosis: pituitary oedema? Eur. J. Endocrinol., May 1, 2009; 160(5): 873 - 875. [Abstract] [Full Text] [PDF]